Voleon Capital Management LP Sarepta Therapeutics, Inc. Transaction History

Voleon Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $1.91 Million - $3.39 Million	-25,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $655,290 - $1.41 Million	-9,000 Reduced 26.47%	25,000 $1.88 Million
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $3.82 Million - $5.17 Million	34,000 New	34,000 $5.17 Million

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $12.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Voleon Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Voleon Capital Management LP with notifications on news.